Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong · Delayed Price · Currency is HKD 4.900
-0.050 (-1.01%)
At close: May 29, 2026
HKG:6922 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -38.17 | -104.37 | -97.49 | -112.22 | -101.87 |
Depreciation & Amortization | 9.26 | 11.84 | 9.41 | 7.62 | 4.47 |
Other Amortization | 0 | 0.02 | 0.02 | 0.02 | 0.01 |
Loss (Gain) From Sale of Assets | 0.06 | 0.01 | - | 0 | 0.11 |
Asset Writedown & Restructuring Costs | - | 9.32 | - | - | - |
Stock-Based Compensation | 14.11 | 16.53 | 19.86 | 20.45 | 17.82 |
Other Operating Activities | -3.8 | -6.28 | -8.75 | -8.6 | 24.73 |
Change in Inventory | -3.15 | -5.77 | -4.71 | -8.12 | -3.62 |
Change in Accounts Payable | 1.29 | 0.3 | -0.86 | 1.45 | 0.13 |
Change in Unearned Revenue | 4.5 | 2.14 | -2.26 | 2.38 | -5.09 |
Change in Other Net Operating Assets | 10.08 | -6.65 | -11.12 | 0.09 | 0.82 |
Operating Cash Flow | -5.82 | -82.91 | -95.89 | -96.94 | -62.49 |
Capital Expenditures | -0.77 | -1.88 | -15.1 | -7.01 | -12.44 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.06 |
Investment in Securities | - | - | - | - | 24.93 |
Other Investing Activities | - | - | - | 0.46 | 3.22 |
Investing Cash Flow | -0.77 | -1.88 | -15.1 | -6.55 | 15.65 |
Short-Term Debt Issued | 74.98 | 35.74 | - | - | - |
Total Debt Issued | 74.98 | 35.74 | - | - | - |
Short-Term Debt Repaid | -75 | -5.74 | - | - | - |
Long-Term Debt Repaid | -2.34 | -4.14 | -5.45 | -2.88 | -2.26 |
Total Debt Repaid | -77.34 | -9.89 | -5.45 | -2.88 | -2.26 |
Net Debt Issued (Repaid) | -2.36 | 25.86 | -5.45 | -2.88 | -2.26 |
Issuance of Common Stock | - | - | - | 187.52 | 204.38 |
Other Financing Activities | -0.9 | -0.39 | -8.24 | -15.24 | -4.37 |
Financing Cash Flow | -3.26 | 25.47 | -13.68 | 169.4 | 197.75 |
Foreign Exchange Rate Adjustments | -0.58 | 1.38 | 1.66 | 2.64 | -0.53 |
Net Cash Flow | -10.43 | -57.94 | -123.02 | 68.56 | 150.38 |
Free Cash Flow | -6.59 | -84.79 | -111 | -103.95 | -74.93 |
Free Cash Flow Margin | -6.92% | -158.39% | -271.05% | -382.87% | -334.11% |
Free Cash Flow Per Share | -0.03 | -0.35 | -0.46 | -0.46 | -0.33 |
Cash Interest Paid | 0.9 | 0.39 | - | - | - |
Cash Income Tax Paid | - | 0.13 | - | - | - |
Levered Free Cash Flow | 4.16 | -65.39 | -85.44 | -49.02 | -49.42 |
Unlevered Free Cash Flow | 5.38 | -64.71 | -85.03 | -48.65 | -49.19 |
Change in Working Capital | 12.72 | -9.98 | -18.94 | -4.2 | -7.76 |